Timing of Thyroxine Dose In Ramadan

Timing of Thyroxine Dose In Ramadan; a Randomized Control Trial

A Randomized trial comparing two different timing of taking thyroxine in patients with Hypothyroidism during fasting the month of Ramadan.

Study Overview

Status

Recruiting

Conditions

Detailed Description

To date there is debate regarding the best timing of L-thyroxine administration during Ramadan as sufficient evidence is lacking. This study aims to compare two-time points of levothyroxine intake during Ramadan focusing on change in TSH, satisfaction and compliance.

A prospective, randomized, open label, multicenter Study. The first group will be will be instructed to take their L-thyroxin dose as per current guidlines at breaking of fast time (sunset) with sip of water then wait 30-60 minutes to consume Iftar meal. The second group (pre-Fajer prayer), patients are going to be instructed to take L-thyroxin dose immediately before start of fast, i.e. Alfajer (dawn) regardless of Suhoor time. The values of Thyroid stimulating hormone (TSH) will be measured two weeks before Ramadan, and 2-4 weeks after Ramadan for comparison.

Study Type

Interventional

Enrollment (Anticipated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jeddah, Saudi Arabia, 21423
        • Recruiting
        • Reem Alamoudi
        • Contact:
        • Sub-Investigator:
          • Samah Nawar, MD
        • Sub-Investigator:
          • Hiba Alharbi, MD
        • Sub-Investigator:
          • Abdullah Alzahrani, MD
        • Principal Investigator:
          • Ali Alqarni, MD
        • Principal Investigator:
          • Yousef Saleh, MD
        • Sub-Investigator:
          • Anwar Borai
        • Sub-Investigator:
          • Majed Ramadan, PhD
      • Jeddah, Saudi Arabia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Saudi patient (males and female) above 18 years with Primary hypothyroidism on levothyroxine replacement who are willing to fast during Ramadan.
  • Patients with controlled thyroid function for last 3 months on same dose of levothyroxine.

Exclusion Criteria:

  • Pregnant or lactating women.
  • Uncontrolled thyroid function test three months prior Ramadan.
  • Thyroid cancer patients who require suppressed TSH.
  • Central Hypothyroidism, patient with acute illness.
  • Patients diagnosed with malabsorption i.e., Celiac Disease, Short bowel, Bariatric surgeries

    • Use of certain Medications like systemic glucocorticoids, activated charcoal, sucralfate, aluminum hydroxide antacid, bile acid sequestrants, iron, calcium carbonate, PPI, rifampicin, and antiepileptic medications
    • Renal or hepatic disease:
    • Creatinine clearance <0.6 ml/s or serum creatinine ≥200 μmol/l
    • Alanine transferase ≥2.5 times the upper limit of normal
    • Active liver disease including jaundice, chronic hepatitis, previous liver transplant
    • Unwillingness to be randomized or to sign informed consent
    • Known Psychiatric Disorders
    • Known uncontrolled substance abuse or alcoholism

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Pre-Iftar (Breaking the fast)
To take thyroxine at breaking of fast with sip of water then wait 30-60 miuntes to eat iftar (breakfast).
Taking thyroxine at two different time points in relation to fasting and food intake; just before dawn and start of fast compared to the usual timing of 30-60minutes after the sunset breakfast meal.
EXPERIMENTAL: Pre-Fajr (Starting the fast)
To take thyroxine immediately before start of fast at predawn time regardless of last meal time.
Taking thyroxine at two different time points in relation to fasting and food intake; just before dawn and start of fast compared to the usual timing of 30-60minutes after the sunset breakfast meal.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thyroid function
Time Frame: 6 - 8 weeks
Change in TSH level
6 - 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 14, 2022

Primary Completion (ANTICIPATED)

August 30, 2022

Study Completion (ANTICIPATED)

October 30, 2022

Study Registration Dates

First Submitted

May 27, 2022

First Submitted That Met QC Criteria

June 12, 2022

First Posted (ACTUAL)

June 16, 2022

Study Record Updates

Last Update Posted (ACTUAL)

June 16, 2022

Last Update Submitted That Met QC Criteria

June 12, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • ICT22J-001-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypothyroidism

Clinical Trials on L-Thyroxine time B (5-15 minutes Before dawn)

3
Subscribe